HIV-1 RNA < 50 copies/mL
1 drugsPredictive biomarker for patient selection in 1 indication
1
Approved Drugs
1
Indications
1
Companies
HIV-1 RNA < 50 copies/mL is a precision-medicine biomarker linked to 1 FDA-approved targeted drug from 1 company, spanning 1 indication including HIV-1 Infection. Explore the targeted therapies, indications, testing methods, and companies developing HIV-1 RNA < 50 copies/mL drugs below.
Search HIV-1 RNA < 50 copies/mL Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting HIV-1 RNA < 50 copies/mL
| Drug | Company | Therapeutic Area |
|---|---|---|
| ODEFSEY | Gilead Sciences | Infectious Disease |